| Literature DB >> 31311800 |
Henna Kallionpää1, Juhi Somani2, Soile Tuomela1, Ubaid Ullah1, Rafael de Albuquerque1, Tapio Lönnberg1, Elina Komsi1, Heli Siljander3,4, Jarno Honkanen3,4, Taina Härkönen3,4, Aleksandr Peet5,6, Vallo Tillmann5,6, Vikash Chandra3,7, Mahesh Kumar Anagandula8, Gun Frisk8, Timo Otonkoski3,7, Omid Rasool1, Riikka Lund1, Harri Lähdesmäki2, Mikael Knip3,4,9,10, Riitta Lahesmaa11.
Abstract
The appearance of type 1 diabetes (T1D)-associated autoantibodies is the first and only measurable parameter to predict progression toward T1D in genetically susceptible individuals. However, autoantibodies indicate an active autoimmune reaction, wherein the immune tolerance is already broken. Therefore, there is a clear and urgent need for new biomarkers that predict the onset of the autoimmune reaction preceding autoantibody positivity or reflect progressive β-cell destruction. Here we report the mRNA sequencing-based analysis of 306 samples including fractionated samples of CD4+ and CD8+ T cells as well as CD4-CD8- cell fractions and unfractionated peripheral blood mononuclear cell samples longitudinally collected from seven children who developed β-cell autoimmunity (case subjects) at a young age and matched control subjects. We identified transcripts, including interleukin 32 (IL32), that were upregulated before T1D-associated autoantibodies appeared. Single-cell RNA sequencing studies revealed that high IL32 in case samples was contributed mainly by activated T cells and NK cells. Further, we showed that IL32 expression can be induced by a virus and cytokines in pancreatic islets and β-cells, respectively. The results provide a basis for early detection of aberrations in the immune system function before T1D and suggest a potential role for IL32 in the pathogenesis of T1D.Entities:
Year: 2019 PMID: 31311800 DOI: 10.2337/db19-0287
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461